Annual report pursuant to Section 13 and 15(d)

SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Cash Flows (Details)

v3.3.1.900
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Cash Flows (Details) - USD ($)
 12 Months Ended
Jun. 23, 2015
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Net cash provided by (used in) operating activities   $ 42,600,618 $ 16,968,553 $ 7,708,012
Proceeds from sale of leased property held for sale   7,678,246 0 0
Increase in financing notes receivable   (524,037) (20,648,714) 0
Principal payment on financing note receivable   100,000 0 0
Net cash (used) provided by in investing activities   (244,612,616) (177,075,793) 5,410,219
Debt financing costs   (1,617,991) (3,269,429) (144,798)
Net offering proceeds on Series A preferred stock   54,210,476 0 0
Net offering proceeds on common stock $ 73,300,000 73,184,679 141,797,913 (523,094)
Net proceeds of convertible debt $ 111,300,000 111,262,500 0 0
Dividends paid on Series A preferred stock   (3,503,125) 0 0
Dividends paid on common stock   (28,528,224) (15,187,976) (8,946,941)
Advances on revolving line of credit   45,392,332 34,676,948 221,332
Payments on revolving line of credit   (77,533,609) (2,617,606) (139,397)
Proceeds from term debt   45,000,000 0 0
Principal payments on term debt   (1,800,000) 0 0
Net cash (used) provided by financing activities   209,052,574 149,722,138 (12,835,748)
Net Change in Cash and Cash Equivalents   7,040,576 (10,385,102) 282,483
Cash and Cash Equivalents at beginning of period   7,578,164 17,963,266 17,680,783
Cash and Cash Equivalents at end of period   14,618,740 7,578,164 17,963,266
Parent Company [Member]        
Net cash provided by (used in) operating activities   18,060,382 (2,047,777) (8,040,654)
Proceeds from sale of leased property held for sale   7,678,246 0 0
Increase in financing notes receivable   0 (90,000,000) 0
Principal payment on financing note receivable   2,570,000 0 0
Investment in consolidated subsidiaries   (261,597,946) (96,570,263) (1,651,956)
Cash distributions from consolidated subsidiaries   23,392,442 18,559,328 19,337,911
Net cash (used) provided by in investing activities   (227,957,258) (168,010,935) 17,685,955
Debt financing costs   (1,439,929) (1,600,908) (30,002)
Net offering proceeds on Series A preferred stock   54,210,476 0 0
Net offering proceeds on common stock   73,184,679 141,797,913 (523,094)
Net proceeds of convertible debt   111,262,500 0 0
Dividends paid on Series A preferred stock   (3,503,125) 0 0
Dividends paid on common stock   (28,528,224) (15,187,976) (8,946,941)
Advances on revolving line of credit   42,000,000 32,000,000 0
Payments on revolving line of credit   (74,000,000) 0 0
Proceeds from term debt   45,000,000 0 0
Principal payments on term debt   (1,800,000) 0 0
Net cash (used) provided by financing activities   216,386,377 157,009,029 (9,500,037)
Net Change in Cash and Cash Equivalents   6,489,501 (13,049,683) 145,264
Cash and Cash Equivalents at beginning of period   3,599,935 16,649,618 16,504,354
Cash and Cash Equivalents at end of period   $ 10,089,436 $ 3,599,935 $ 16,649,618